Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections

BACKGROUND: Humoral and cellular immune responses are known to be crucial for patients to recover from COVID-19 and to protect them against SARS-CoV-2 reinfection once infected or vaccinated. OBJECTIVES: This study aimed to investigate humoral and T cell responses to SARS-CoV-2 vaccination in patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Egri, Natalia, Calderón, Hugo, Martinez, Robert, Vazquez, Mario, Gómez-Caverzaschi, Verónica, Pascal, Mariona, Araújo, Olga, Juan, Manel, González-Navarro, Europa Azucena, Hernández-Rodríguez, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174323/
https://www.ncbi.nlm.nih.gov/pubmed/37180097
http://dx.doi.org/10.3389/fimmu.2023.1146841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174323/
https://www.ncbi.nlm.nih.gov/pubmed/37180097
http://dx.doi.org/10.3389/fimmu.2023.1146841

Ejemplares similares